(Source: Biota Pharmaceuticals Inc) ATLANTA, April 12, 2016 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) today announced that the Company has changed its name to Aviragen Therapeutics, Inc., ('Aviragen Therapeutics'), a pharmaceutical company focused on the development of the next generation of direct-acting antivirals that address infections that have limited therapeutic options. 'A meaningful transformation has taken place over the last two years as we transitioned from a drug discovery and early-stage licensing organization to one focused on drug development and progressing key late-stage product candidates in important viral diseases. Our name change reflects this...
↧